Cargando…

Atypical Macropinocytosis Contributes to Malignant Progression: A Review of Recent Evidence in Endometrioid Endometrial Cancer Cells

SIMPLE SUMMARY: A novel type of macropinocytosis has been identified as a trigger for the malignant progression of endometrial cancer. Transiently reducing epithelial barrier homeostasis leads to macropinocytosis by splitting between adjacent cells in endometrioid endometrial cancer. Macropinocytosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kohno, Takayuki, Kojima, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599675/ https://www.ncbi.nlm.nih.gov/pubmed/36291839 http://dx.doi.org/10.3390/cancers14205056

Ejemplares similares

Look at This Swelling: Retroauricular Mass as Atypical Progression in Long-Survivor Endometrial Endometrioid Adenocarcinoma
por: De Felice, Marco, et al.
Publicado: (2023)

The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer
por: Guan, Jun, et al.
Publicado: (2022)

The Roles of Tricellular Tight Junction Protein Angulin-1/Lipolysis-Stimulated Lipoprotein Receptor (LSR) in Endometriosis and Endometrioid-Endometrial Carcinoma
por: Shimada, Hiroshi, et al.
Publicado: (2021)

Effectiveness of Megestrol for the Treatment of Patients with Atypical Endometrial Hyperplasia or Endometrial Endometrioid Adenocarcinoma (Stage IA, Well Differentiated)
por: Akhavan, Setareh, et al.
Publicado: (2021)

Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma
por: Yoneoka, Yutaka, et al.
Publicado: (2018)

Malignant Transformation from Endometriosis to Atypical Endometriosis and Finally to Endometrioid Adenocarcinoma within 10 Years
por: Tanase, Yasuhito, et al.
Publicado: (2013)

Hypoxia and Angiogenesis in Endometrioid Endometrial Carcinogenesis
por: Horrée, Nicole, et al.
Publicado: (2007)

VEGF Immunoexpression in Endometrioid Endometrial Carcinomas
por: DROCAŞ, ILEANA, et al.
Publicado: (2022)

Snail Immunoexpression in Endometrioid Endometrial Carcinomas
por: FLORESCU, MIRELA MARINELA, et al.
Publicado: (2022)

RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma
por: Liu, Shuang, et al.
Publicado: (2019)

Rapid identification of endometrial hyperplasia and endometrial endometrioid cancer in young women
por: Kuai, Dan, et al.
Publicado: (2023)

Role of serum microRNAs as biomarkers for endometriosis, endometrioid carcinoma of ovary & endometrioid endometrial cancer
por: Kumari, Priti, et al.
Publicado: (2022)

Use of clinicopathological factors to predict prognosis of fertility-sparing treatment for endometrial endometrioid carcinoma and atypical hyperplasia
por: Zhang, Xiaobo, et al.
Publicado: (2022)

Clinicopathological Prognostic Parameters of Endometrioid Endometrial Carcinomas
por: DROCAŞ, ILEANA, et al.
Publicado: (2022)

Long-term survival of endometrioid endometrial cancer patients
por: Gottwald, Leszek, et al.
Publicado: (2010)

Tumor grade and chemotherapy response in endometrioid endometrial cancer
por: Davidson, Brittany A., et al.
Publicado: (2016)

An integrated prediction model of recurrence in endometrial endometrioid cancers
por: Miller, Marina D, et al.
Publicado: (2019)

Endothelin-3 is epigenetically silenced in endometrioid endometrial cancer
por: Zmarzły, Nikola, et al.
Publicado: (2022)

Clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid carcinoma
por: Kobayashi Kato, Mayumi, et al.
Publicado: (2022)

PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia
por: Xue, Yu, et al.
Publicado: (2023)

The roles of tricellular tight junction protein lipolysis-stimulated lipoprotein receptor in malignancy of human endometrial cancer cells
por: Shimada, Hiroshi, et al.
Publicado: (2016)

EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
por: Alldredge, Jill K., et al.
Publicado: (2017)

An exploratory analysis of γ-synuclein expression in endometrioid endometrial cancer
por: Zou, Jing, et al.
Publicado: (2012)

Impact of genomic stability on protein expression in endometrioid endometrial cancer
por: Lomnytska, M I, et al.
Publicado: (2012)

Molecular Landscape of the Epithelial–Mesenchymal Transition in Endometrioid Endometrial Cancer
por: Opławski, Marcin, et al.
Publicado: (2021)

Expression Pattern of Leptin and Its Receptors in Endometrioid Endometrial Cancer
por: Boroń, Dariusz, et al.
Publicado: (2021)

Extragonadal Giant Endometrial Cyst with Endometrioid Borderline Tumor
por: Yazawa, Hiroyuki, et al.
Publicado: (2019)

Identification of potential models for predicting progestin insensitivity in patients with endometrial atypical hyperplasia and endometrioid endometrial cancer based on ATAC-Seq and RNA-Seq integrated analysis
por: Hu, Jia-Li, et al.
Publicado: (2022)

Discriminating miRNA Profiles between Endometrioid Well- and Poorly-Differentiated Tumours and Endometrioid and Serous Subtypes of Endometrial Cancers
por: Kalinkova, Lenka, et al.
Publicado: (2020)

L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma
por: Geels, Yvette P., et al.
Publicado: (2016)

Characterization of the endometrial, cervicovaginal and anorectal microbiota in post-menopausal women with endometrioid and serous endometrial cancers
por: Gressel, Gregory M., et al.
Publicado: (2021)

Hysteroscopic Curettage Followed by Megestrol Acetate Plus Metformin as a Fertility-Sparing Treatment for Women with Atypical Endometrial Hyperplasia or Well-Differentiated Endometrioid Endometrial Carcinoma
por: Jing, Chu-Yu, et al.
Publicado: (2022)

Prognostic and Clinical Significance of miRNA-205 in Endometrioid Endometrial Cancer
por: Wilczynski, Milosz, et al.
Publicado: (2016)

Thrombocytosis as a Biomarker in Type II, Non-Endometrioid Endometrial Cancer
por: Bussies, Parker, et al.
Publicado: (2020)

Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth
por: Blankenship, Logan, et al.
Publicado: (2022)

Endometrioid endometrial cancer treated with open or laparoscopic approach: is there a dilemma?
por: Iavazzo, Christos, et al.
Publicado: (2023)

Circulating microRNAs as a Fingerprint for Endometrial Endometrioid Adenocarcinoma
por: Wang, Lin, et al.
Publicado: (2014)

An Unusual Solitary Metatarsal Metastasis from an Endometrioid Endometrial Adenocarcinoma
por: Longo, Raffaele, et al.
Publicado: (2015)

The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas
por: Zhan, Xiangbo, et al.
Publicado: (2019)

Biomarkers Associated with Lymph Nodal Metastasis in Endometrioid Endometrial Carcinoma
por: Mairé, Mathilde, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_17kvkqu7gv3vv9f3dq3et6lrgn